Psilocybin Found to Prevent Chemotherapy-Induced Nerve Damage in Preclinical Study
Here's what it means for you.
This breakthrough could redefine supportive care in oncology, enhancing treatment adherence and quality of life for cancer patients.
What happened
Researchers at The University of Texas MD Anderson Cancer Center found that psilocybin can prevent chemotherapy-induced peripheral neuropathy in mouse models.
The Context
- Chemotherapy-induced peripheral neuropathy (CIPN) affects up to 60% of patients on certain chemotherapy regimens, leading to chronic pain and treatment discontinuation.
- Psilocybin's neuroprotective effects were demonstrated through two doses before chemotherapy cycles, preserving nerve function without compromising cancer treatment efficacy.
- A Phase 2 clinical trial is set to begin in November 2026, aiming to validate these findings in human patients with various cancers.
The Number
— This is the proportion of patients receiving platinum-based chemotherapy who develop CIPN, highlighting the urgent need for effective preventive measures in oncology.
Takeaway
If clinical trials confirm these findings, psilocybin could become a vital adjunct therapy, improving outcomes for cancer patients worldwide.
Health trends, medical research, and fitness reporting.
"The New York Times is a globally recognized newspaper offering authoritative reporting with a center-left editorial stance."
— A47 Editor
Psilocybin May Prevent Nerve Damage Caused by Chemotherapy, Study Finds
A recent study indicates that psilocybin, a psychedelic compound, may help prevent nerve damage caused by chemotherapy, based on preliminary research conducted in mice. This finding is particularly significant as neuropathy, a common side effect of c...
Scientific research, space, environment, and health coverage.
"The New York Times is a globally recognized newspaper offering authoritative reporting with a center-left editorial stance."
— A47 Editor
Psilocybin May Prevent Nerve Damage Caused by Chemotherapy, Study Finds
A recent study indicates that psilocybin, a psychedelic compound, may help prevent nerve damage caused by chemotherapy, based on preliminary research conducted in mice. This finding is particularly significant as neuropathy, a common side effect of c...
Scientific discoveries, health, technology, and natural phenomena.
"Live Science reports on scientific discoveries, health, technology, and natural phenomena with a popular science tone."
— A47 Editor
Psilocybin may protect against a common, debilitating side effect of chemotherapy, early study finds
Early research suggests that psilocybin, a psychedelic compound known for its effects on the brain, may protect peripheral nerves from damage caused by chemotherapy. This finding indicates a potential new therapeutic avenue for addressing neuropathy,...
Science and technology stories including AI.
"Longstanding science magazine with thoughtful AI coverage."
— A47 Editor
‘Unparalleled’ study finds psilocybin protects against nerve damage from chemotherapy
A recent study has revealed that psilocybin, a compound found in magic mushrooms, may offer protection against nerve damage caused by chemotherapy in mice. This groundbreaking research suggests a potential new avenue for mitigating a common and debil...
Scientific research, technology, environment, and society.
"Scientific American is one of the oldest and most authoritative science magazines, known for deep dives into science, technology, and society."
— A47 Editor
‘Unparalleled’ study finds psilocybin protects against nerve damage from chemotherapy
A recent study has revealed that psilocybin, a compound found in magic mushrooms, may offer protection against nerve damage caused by chemotherapy in mice. This groundbreaking research suggests a potential new avenue for mitigating a common and debil...